Daily Journal Staff Writer
Specialty drugmaker Amphastar Pharmaceuticals Inc. filed for an initial public offering with the help of K&L Gates LLP on Tuesday amid a recent resurgence of investor interest in the technology and life science industries.
The move could net the company up to $100 million, according to its filing with the Securities and Exchange Commission.
Irvine-based partners David B. Allen and Mich...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In